single5MG
Ipamorelin
5MG Protocol
Ipamorelin 5MG
Injection Freq.
Inject once daily
Cycle Sched.
8–12 weeks; optional extension to 16 weeks, followed by 2–4 week off-cycle
Reconstitution
3.0 mL BAC water
Supports lean-mass and recovery signaling via GH-mediated anabolic processes
Supports fat-metabolism and favorable body-composition changes over time
High selectivity for GH release with minimal ACTH/cortisol/prolactin impact
May support gastric motility and digestive function
1
Reconstitution Requirements
- 3.0 mL BAC water
| Step | Week Range | Dose | Units |
|---|---|---|---|
| 1 | Weeks 1–2 | 100 mcg | 6 |
| 2 | Weeks 3–4 | 150 mcg | 9 |
| 3 | Weeks 5–8 | 200 mcg | 12 |
| 4 | Weeks 9–12 | 250 mcg | 15 |
Inject once daily
8–12 weeks; optional extension to 16 weeks, followed by 2–4 week off-cycle
Ipamorelin works by binding to the growth hormone secretagogue receptor (GHSR-1a) to stimulate the pituitary gland to release growth hormone in discrete pulses. The protocol emphasizes that this GH release is transient—peaking around 40 minutes after a subcutaneous injection and resolving within a few hours—so the overall endocrine signal resembles a physiologic pulse rather than continuous stimulation. The page describes ipamorelin as comparatively selective among GH secretagogues, with minimal stimulation of ACTH, cortisol, or prolactin at typical research doses, which is one reason it is often positioned as a “cleaner” secretagogue profile. In addition to pituitary effects, ipamorelin’s receptor activity in the gastrointestinal tract is noted; studies described on the page associate GHSR-1a activation with enhanced gastric motility and faster gastric emptying. Taken together, the mechanism is short-acting, selective GH pulse generation plus potential pro-motility effects.
Mild injection-site reactions (redness/swelling)
Very rare water retention
Very rare increased hunger
- Use aseptic technique: wipe vial stopper with alcohol; use new sterile syringe/needle
- Add diluent slowly down the vial wall to minimize foaming
- Gently swirl/roll until fully dissolved (do not shake)
- Label vial with reconstitution date and concentration; protect from light
- Refrigerate after reconstitution (commonly 2–8 °C) unless protocol states otherwise
- Avoid repeated freeze–thaw cycles
- Bacteriostatic Water for Injection contains benzyl alcohol preservative (multi-dose); follow protocol for beyond-use (many peptide protocols use ~28 days after mixing)
- Avoid benzyl-alcohol-containing diluents in neonates/infants (safety warning for benzyl alcohol)